{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:09:40Z","timestamp":1787004580183,"version":"build-2736575974"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>\n                    Transplant\u2010related mortality (TRM) remains a major problem in older patients undergoing allogeneic haemopoietic stem cell transplants (HSCTs). We have therefore explored a less intensive conditioning in 33 patients with a median age of 52\u2003years (range 43\u201360) transplanted from human leucocyte antigen (HLA)\u2010identical siblings. The underlying disease was chronic myeloid leukaemia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200315), acute myeloid leukaemia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u20036), myelodysplasia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u20037) or a chronic lymphoproliferative disorder (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u20035); 15 patients (45%) had advanced disease. The regimen consisted of thiotepa (THIO; 10\u2003mg\/kg) on day \u22125 and cyclophosphamide (CY; 50\u2003mg\/kg) on days \u22123 and \u22122 (total dose 100\u2003mg\/kg). The source was bone marrow (BM) (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200317) or granulocyte colony\u2010stimulating factor (G\u2010CSF)\u2010mobilized peripheral blood (PB) (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200316), which were infused without manipulation. Graft\u2010versus\u2010host disease (GVHD) prophylaxis consisted of cyclosporin A (CyA) and a short course of methotrexate. Mean time to achieve a neutrophil count of 0\u00b75\u2003\u00d7\u200310\n                    <jats:sup>9<\/jats:sup>\n                    \/l was 17\u2003d (range 11\u201323) and full donor chimaerism was detected in 79% of patients by day 100. Acute GVHD grade III or IV occurred in 3% of patients. Chronic GVHD was seen in 45% of patients, with a significant difference for PB (69%) compared with BM transplants (23%) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030\u00b7009). For BM grafts, the actuarial 2\u2010year TRM was 6%, the relapse 56% and survival 87%; for PB grafts, these figures were, respectively, 27%, 33% and 68%. Twenty\u2010five patients are alive at a median follow\u2010up of 762\u2003d (range 216\u20131615) and 20 patients (60%) remain free of disease. Thirteen patients (39%) received donor lymphocyte infusion (DLI) either for persisting or relapsing disease and six patients had complete remission. In conclusion: (i) patients up to the age of 60\u2003years can be allografted with reduced intensity conditioning; (ii) the procedure was associated with a low transplant\u2010related mortality, particularly for bone marrow grafts, because of a lower risk of chronic GVHD; and (iii) DLI were required after transplant in half the patients for persisting disease or relapse.\n                  <\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02123.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T01:25:35Z","timestamp":1047345935000},"page":"716-721","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Reduced intensity thiotepa\u2013cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60\u2003years of age"],"prefix":"10.1111","volume":"109","author":[{"given":"A. M.","family":"Raiola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lamparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gualandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mordini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Berisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bregante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sessarego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fugazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.150009"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701269"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T\u2010cell\u2010depleted haploidentical \u2018three\u2010loci\u2019 incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony\u2010stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa F.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702385"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood.V88.1.353.353","article-title":"Thiotepa cyclophosphamide followed by granulocyte colony\u2010stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia","volume":"88","author":"Bacigalupo A.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_7_1","first-page":"409","article-title":"Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single\u2010center experience","volume":"26","author":"Bacigalupo A.","year":"1998","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.806"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1867.1867"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701103"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.15.1221"},{"key":"e_1_2_6_12_1","first-page":"618a","article-title":"Haematopoietic precursor cell transplants, main risk factors","volume":"86","author":"Gratwohl A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03030-X"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant lite: Induction of graft\u2010versus\u2010malignancy using fludarabine\u2010based non\u2010ablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancy","volume":"8","author":"Khouri I.F.","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911270-00010"},{"key":"e_1_2_6_16_1","first-page":"555","article-title":"High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies","volume":"17","author":"Majolino I.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_17_1","first-page":"518a","article-title":"Outpatient PBSC allografts using immunosuppression with low\u2010dose TBI before and cyclosporine (CSA) and mycophenolate mofetil (MMF) after transplant","volume":"92","author":"McSweeny P.A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_18_1","first-page":"994","volume-title":"Hematology: Basic Principles and Practice","author":"Miller K.B.","year":"1995"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701758"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701234"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Non\u2010myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.986"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02123.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02123.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T06:00:13Z","timestamp":1698559213000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02123.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02123.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02123.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}